The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

CeHV15ggp350  -  gp350

Macacine herpesvirus 4

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CeHV15ggp350

  • As an initial application, a live recombinant VZV expressing Epstein-Barr virus (EBV) membrane glycoproteins (gp350/220) was generated by inserting a gene fusion of the VZV gpI promoter and hydrophobic leader-encoding sequence with the gp350/220 coding sequence into the thymidine kinase (TK) gene of VZV (Oka) [1].
  • The results suggest that gp350 may be effective as an immunogen to prevent EBV-associated infectious mononucleosis in humans that are EBV-seronegative [2].
 

High impact information on CeHV15ggp350

  • RNA splicing, glycosylation, and plasma membrane presentation of gp350/220 in cells infected with the recombinant virus were similar to those seen in EBV-infected cells [1].
  • The human gammaherpesviruses Epstein-Barr virus and Kaposi Sarcoma-associated herpesvirus both contain a glycoprotein (gp350/220 and K8.1, respectively) that mediates binding to target cells and has been studied in great detail in vitro [3].
  • In these experiments we were able to demonstrate the feasibility of our approach for the investigation of EBV-specific ADCC reactions and could confirm the role of gp 350/220 as an ADCC target [4].
  • The resulting transformed 'integrant' cells produced approximately five-fold more gp350 mRNA and ten-fold more gp350-related proteins than the transformed 'non-integrant' cells following galactose induction [5].
 

Biological context of CeHV15ggp350

  • Recently, the viral membrane protein gp 350/220, which is also expressed at the surface of the virus producing cell, was identified as a target for ADCC reactions [4].

References

  1. Varicella-zoster virus as a live vector for the expression of foreign genes. Lowe, R.S., Keller, P.M., Keech, B.J., Davison, A.J., Whang, Y., Morgan, A.J., Kieff, E., Ellis, R.W. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  2. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Stewart, J.P., Micali, N., Usherwood, E.J., Bonina, L., Nash, A.A. Vaccine (1999) [Pubmed]
  3. In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis. Stewart, J.P., Silvia, O.J., Atkin, I.M., Hughes, D.J., Ebrahimi, B., Adler, H. J. Virol. (2004) [Pubmed]
  4. The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC). Jilg, W., Bogedain, C., Mairhofer, H., Gu, S.Y., Wolf, H. Virology (1994) [Pubmed]
  5. Regulated overproduction of the GAL4 gene product greatly increases expression from galactose-inducible promoters on multi-copy expression vectors in yeast. Schultz, L.D., Hofmann, K.J., Mylin, L.M., Montgomery, D.L., Ellis, R.W., Hopper, J.E. Gene (1987) [Pubmed]
 
WikiGenes - Universities